NCT06271538View on ClinicalTrials.gov

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

November 30, 2025

Conditions
Irritable Bowel SyndromeGastrointestinal DiseasesColonic Diseases, FunctionalIntestinal DiseaseDigestive System DiseasePathologic ProcessesColonic DiseaseDisease
Interventions
COMBINATION_PRODUCT

Skal Pro

One sachet Skal Pro per day containing Lactobacillus plantarum 299v 1x10\^10 CFU and GOS

OTHER

Placebo

One sachet per day identical in shape, size, colour, packaging and taste to the Skal Pro sachet

Trial Locations (1)

16150

RECRUITING

Hospital Universiti Sains Malaysia, Kubang Kerian

All Listed Sponsors
lead

EP Plus Group Sdn Bhd

INDUSTRY